Institut für Nuklearmedizin

Treatments according to OPS

Service Number of cases OPS key Info
Visualisation of the metabolic processes in the trunk with radioactive labelled substances and computed tomography (PET/CT) 48 3-752.0
Imaging procedure to show the musculoskeletal system using nuclear radiation (scintigraphy) 43 3-705.0
Imaging procedure to show the lymphatic system by means of radioactivity (scintigraphy) 41 3-709.x
Visualisation of the metabolic processes in the whole body with radioactive labelled substances and computed tomography (PET/CT) 25 3-753.0
Imaging procedure to show the lungs by means of radioactivity and computed tomography (SPECT) 24 3-722.0
Imaging procedure to show the musculoskeletal system using nuclear radiation (scintigraphy) 16 3-705.1
Imaging procedure to show the kidneys by means of radioactivity (scintigraphy) 14 3-706.1
Imaging procedure to show the thyroid gland by means of radioactivity (scintigraphy) 7 3-701
Imaging procedure to show the heart by means of radioactivity and computed tomography (SPECT) 5 3-721.21
Imaging procedure to show other hormone-producing organs by means of radioactivity (scintigraphy) not specified 3-702.0
Imaging procedure to show the haematopoietic system (in bone marrow, liver and/or spleen) by means of radioactivity (scintigraphy) not specified 3-70a.1
Imaging procedure to show the heart by means of radioactivity and computed tomography (SPECT) not specified 3-721.01
Visualisation of the metabolic processes in the brain with radioactive labelled substances and computed tomograph (PET/CT) not specified 3-750
Visualisation of the metabolic processes in the heart with radioactive labelled substances and computed tomography (PET/CT) not specified 3-751
Visualisation of the metabolic processes in the trunk with radioactive labelled substances and computed tomography (PET/CT) not specified 3-752.1
Visualisation of the metabolic processes in the whole body with radioactive labelled substances and computed tomography (PET/CT) not specified 3-753.1
Gamma probe measurement when removing a particular lymph node in cancerous diseases, e.g. with breast cancer not specified 3-760